PL385972A1 - Pharmaceutical composition for therapy of parodonthium deseases - Google Patents

Pharmaceutical composition for therapy of parodonthium deseases

Info

Publication number
PL385972A1
PL385972A1 PL385972A PL38597208A PL385972A1 PL 385972 A1 PL385972 A1 PL 385972A1 PL 385972 A PL385972 A PL 385972A PL 38597208 A PL38597208 A PL 38597208A PL 385972 A1 PL385972 A1 PL 385972A1
Authority
PL
Poland
Prior art keywords
parodonthium
deseases
therapy
pharmaceutical composition
pharmaceutical
Prior art date
Application number
PL385972A
Other languages
Polish (pl)
Other versions
PL219098B1 (en
Inventor
Maciej Siewiński
Katarzyna Małolepsza-Jarmołowska
Original Assignee
Akademia Medyczna im. Piastów Śląskich we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademia Medyczna im. Piastów Śląskich we Wrocławiu filed Critical Akademia Medyczna im. Piastów Śląskich we Wrocławiu
Priority to PL385972A priority Critical patent/PL219098B1/en
Priority to EP09737192A priority patent/EP2349199A2/en
Priority to PCT/PL2009/050024 priority patent/WO2010024702A2/en
Publication of PL385972A1 publication Critical patent/PL385972A1/en
Publication of PL219098B1 publication Critical patent/PL219098B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
PL385972A 2008-08-28 2008-08-28 Pharmaceutical composition for therapy of parodonthium deseases PL219098B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL385972A PL219098B1 (en) 2008-08-28 2008-08-28 Pharmaceutical composition for therapy of parodonthium deseases
EP09737192A EP2349199A2 (en) 2008-08-28 2009-08-28 Pharmaceutical composition for the treatment of periodontal diseases
PCT/PL2009/050024 WO2010024702A2 (en) 2008-08-28 2009-08-28 Pharmaceutical composition for the treatment of periodontal diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL385972A PL219098B1 (en) 2008-08-28 2008-08-28 Pharmaceutical composition for therapy of parodonthium deseases

Publications (2)

Publication Number Publication Date
PL385972A1 true PL385972A1 (en) 2010-03-01
PL219098B1 PL219098B1 (en) 2015-03-31

Family

ID=41343718

Family Applications (1)

Application Number Title Priority Date Filing Date
PL385972A PL219098B1 (en) 2008-08-28 2008-08-28 Pharmaceutical composition for therapy of parodonthium deseases

Country Status (3)

Country Link
EP (1) EP2349199A2 (en)
PL (1) PL219098B1 (en)
WO (1) WO2010024702A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012113037A1 (en) * 2011-02-25 2012-08-30 The University Of Melbourne Method for inhibiting proteins
RU2606040C2 (en) * 2015-04-01 2017-01-10 Ирина Николаевна Усманова Method for treating chronic inflammation of paradentium tissues and mucous membrane with hyperkeratosis in young individuals
RU2637413C1 (en) * 2016-07-04 2017-12-04 Ирина Николаевна Усманова Method for treatment of oral mucosa chronic inflammation with hyperkeratosis elements in young persons
PL239917B1 (en) * 2018-11-28 2022-01-24 Univ Medyczny Im Piastow Slaskich We Wroclawiu Implantological composition containing cystatin and its composition in bone implantology
WO2020167152A1 (en) * 2019-02-15 2020-08-20 RAPAK, Andrzej Marek Inhibitors of cysteine peptidases isolated from natural raw materials and use of the inhibitors in medicine and veterinary medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4592127B2 (en) * 1999-03-30 2010-12-01 雪印乳業株式会社 Bone resorption inhibitor
PL190404B1 (en) * 1999-08-02 2005-12-30 Akad Medyczna Pharmacological agent effectively acting against neoplasms, pathogenic micro-organisms and invasive diseases
PL195665B1 (en) * 2000-06-13 2007-10-31 Przed Farmaceutyczne Jelfa Sa Pharmacological agent for local application in treating parodontium diseases
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents

Also Published As

Publication number Publication date
EP2349199A2 (en) 2011-08-03
PL219098B1 (en) 2015-03-31
WO2010024702A3 (en) 2011-06-03
WO2010024702A2 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
EP2291157A4 (en) Compositions and methods for the transdermal delivery of pharmaceutical compounds
PT2482812T (en) Therapeutic uses of pharmaceutical compositions
HK1253355A1 (en) Therapeutic compositions containing macitentan
PT2322221E (en) Pharmaceutical composition for treatment and prevention of cancer
LT2303330T (en) Pharmaceutical compositions for treatment of parkinson`s disease
IL211293A (en) Combination of agents for preparation of medication for tuberculosis therapy
HK1141447A1 (en) Pharmaceutical composition for the treatment of proliferative diseases
EP2236149A4 (en) Medicinal composition
HUE039768T2 (en) Therapeutic agent for anaerobic diseases
EP2465512A4 (en) Pharmaceutical composition for suppressing pain
EP2268278A4 (en) Pharmaceutical composition
PL385972A1 (en) Pharmaceutical composition for therapy of parodonthium deseases
EP2236148A4 (en) Medicinal agent for anti-helicobacter therapy
HK1155659A1 (en) Pharmaceutical composition for treatment of fibromyalgia
IL213711A (en) Pharmaceutical formulation of nanonised fenofibrate
EP2377934A4 (en) Pharmaceutical composition for treatment of cancer and asthma
PL2331092T3 (en) Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
PL2305300T3 (en) Pharmaceutical composition for treatment and prevention of cancer
IL200753A (en) Pharmaceutical composition comprising ib-meca for the treatment of psoriasis
HK1145399A1 (en) Pharmaceutical composition for treating hemorrhoids
HK1131039A1 (en) Pharmaceutical use of sophoricoside
EP2460524A4 (en) Medicinal composition for iontophoresis
GB0817969D0 (en) Pharmaceutical composition
EP2329824A4 (en) Novel pharmaceutical composition for treatment of nociceptive pain
IL215854A0 (en) Pharmaceutical compositions for the treatment of nasal polyposis